vestarВестник аритмологииJournal of Arrhythmology1561-86412658-7327НАО «Инкарт»10.35336/VA-2020-2-45-47vestar-252Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCASE REPORTSКлинический случай криобаллонной изоляции устьев легочных вен у пациента с пароксизмальной формой фибрилляции предсердий после закрытия дефекта межпредсердной перегородки окклюдером «Amplatzer»Clinical case of cryoballoon pulmonary vein isolation in patient with paroxysmal form of atrial fibrillation after atrial septal defect closure using «Amplatzer» occludeТаймасоваИ. А.TaymasovaI. A.

Таймасова Ирина Азатовна

Москва

Irina Taymasova

irina-tame@yandex.ruЯшковМ. В.YashkovM. V.

Москва

Moscow

КадыроваМ.KadirovaM.

Москва

Moscow

АртюхинаЕ. А.ArtyukhinaE. A.

Москва

Moscow

ФГБУ Национальный медицинский исследовательский центр хирургии им. А.В.Вишневского Минздрава РоссииРоссияA.V. Vishnevskiy National Medical Research Center of Surgery of the Ministry of Health of the Russian FederationRussian Federation2020240720202724547Copyright © Таймасова И.А., Яшков М.В., Кадырова М., Артюхина Е.А., 20202020Таймасова И.А., Яшков М.В., Кадырова М., Артюхина Е.А.Taymasova I.A., Yashkov M.V., Kadirova M., Artyukhina E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vestar.elpub.ru/jour/article/view/252

Описывается клинический случай криобаллонной изоляции легочных вен у пациента с имплантированным ранее окклюдером «Amplatzer» по поводу врожденного порока сердца - дефекта межпредсердной перегородки.

There is description of clinical case of cryoballoon pulmonary vein isolation in patient with atrial septal defect closure devise - occluder “Amplatzer”.

дефект межпредсердной перегородкиокклюдерфибрилляция предсердийкриобаллонная изоляцияatrial septal defectoccluderatrial fibrillationcryoballoon isolationReferencesSpies C, Khandelwal A, Timmermanns I, et al. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults. American Journal of Cardiology. 2008;102 902-906. DOI: 10.1016/j.amjcard.2008.05.045Spies C, Khandelwal A, Timmermanns I, et al. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults. American Journal of Cardiology. 2008;102 902-906. DOI: 10.1016/j.amjcard.2008.05.045Donti A, Bonvinci M, Placci A, et al. Surgical treatment of secundum atrial septal defects in patients older than 50 years. Italian Heart Journal. 2001;2: 428-432. PMID: 11453578.Donti A, Bonvinci M, Placci A, et al. Surgical treatment of secundum atrial septal defects in patients older than 50 years. Italian Heart Journal. 2001;2: 428-432. PMID: 11453578.Berger F, Ewert P, Bjornstad PG, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer septal occluder. Cardiology Young. 1999;9: 468-473. DOI: 10.1017/s1047951100005369.Berger F, Ewert P, Bjornstad PG, et al. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer septal occluder. Cardiology Young. 1999;9: 468-473. DOI: 10.1017/s1047951100005369.Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37(38): 2893-2962. DOI:10.1093/eurheartj/ehw210.Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37(38): 2893-2962. DOI:10.1093/eurheartj/ehw210.Santangeli P, Di Biase L, Burkhardt JD, et al. Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices. Heart Rhythm. 2011;8(11): 1669-1675. D0I:10.1016/j.hrthm.2011.06.023.Santangeli P, Di Biase L, Burkhardt JD, et al. Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices. Heart Rhythm. 2011;8(11): 1669-1675. D0I:10.1016/j.hrthm.2011.06.023.Sang C-H, Dong J-Z, Long D-Y, et al. Transseptal puncture and catheter ablation of atrial fibrillation in patients with atrial septal occluder: initial experience of a single centre. Europace. 2017;10(1): 101-107. DOI:10.1093/europace/eux282.Sang C-H, Dong J-Z, Long D-Y, et al. Transseptal puncture and catheter ablation of atrial fibrillation in patients with atrial septal occluder: initial experience of a single centre. Europace. 2017;10(1): 101-107. DOI:10.1093/europace/eux282.Li X, Wissner E, Kamioka M, et al. Safety and feasibility of transseptal puncture for atrial fibrillation ablation in patients with atrial septal defect closure devices. Heart Rhythm. 2014; 11(2): 330-335. DOI:10.1016/j.hrthm.2013.11.011.Li X, Wissner E, Kamioka M, et al. Safety and feasibility of transseptal puncture for atrial fibrillation ablation in patients with atrial septal defect closure devices. Heart Rhythm. 2014; 11(2): 330-335. DOI:10.1016/j.hrthm.2013.11.011.Ревишвили АШ, Рзаев ФГ, Сопов ОВ и др. Интервенционное лечение фибрилляции предсердий с использованием внутрисердечной эхокардиографии у пациента после билатеральной миниинвазивной торакоскопической радиочастотной изоляции легочных вен и закрытия открытого овального окна окклюдером «Amplatzer». Анналы аритмологии. 2008;4: 70-78.Revishvili ASh, Rzaev FG, Sopov OV, et al. Interventional treatment of atrial fibrillation using intracardiac ultrasound in patient with bilateral mini-invasive thoracoscopic radiofrequency isolation of pulmonary veins and atrial septal closure with “Amplatzer" occluder. Annals of arrhythmology. 2008;4: 70-78. (In Russ.).

The authors declare that there are no conflicts of interest present.